The NIH and Department of Defense have quietly confirmed a signed agreement, disclosed the Friday before a US holiday, that redirects part of the NIH's National Institute of Allergy and Infectious Diseases budget toward Pentagon research on pandemic flu, CBRN threats and emerging infectious diseases. The deal runs a decade, and while the exact dollar amount is unspecified, reports indicate the Pentagon sought roughly a third of relevant funding but was steered toward about 10 percent instead.
arstechnica.com
· 2026-09-08
Two NIH employees say the agency has signed an agreement with the Department of Defense to transfer research projects, currently valued in the hundreds of millions of dollars, from its infectious-diseases institute to military biodefence programs. The NIH is reportedly still selecting which projects to hand over and hopes to finalize the deal before the fiscal year ends in September, when certain funds would otherwise expire. NIH officials describe the move as separating civilian public-health work from defense-related priorities, while a former top HHS lawyer questions whether simply redirecting funds between agencies in this way is legally permissible.
nature.com
· 2026-09-04
GoKawiil